Fluxion is the leader in liquid biopsies. Our ERASE-Seq NGS solution is a background-aware variant caller that allows ultra-sensitive somatic mutation detection without molecular barcodes. The IsoFlux Liquid Biopsy System is the leading platform for analysis of circulating tumor cells (CTCs), with complete solutions for enumeration, marker detection, and NGS.
Service offerings include liquid biopsy processing for clinical trials, development of novel CTC isolation markers, clinical research projects, and custom bioinformatics development.